Samalin Investment Counsel, LLC Merck & Co., Inc. Transaction History

Samalin Investment Counsel, LLC

$222 Million
Q3 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 9,552 shares of MRK stock, worth $935,331. This represents 0.49% of its overall portfolio holdings.

Number of Shares

9,552

Previous 6,944 37.56%

Holding current value

$935,331

Previous $859,000 26.19%

% of portfolio

0.49%

Previous 0.42%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $289,879 - $336,353	2,608 Added 37.56%	9,552 $1.08 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $1,361 - $1,462	-11 Reduced 0.16%	6,944 $859,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $4,869 - $5,673	43 Added 0.62%	6,955 $917,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $22,740 - $24,747	227 Added 3.4%	6,912 $753,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $9,059 - $10,061	88 Added 1.33%	6,685 $688,000
Q2 2023 Aug 03, 2023	BUY	$108.61 - $118.38 $31,605 - $34,448	291 Added 4.61%	6,597 $761,000
Q1 2023 May 09, 2023	BUY	$102.94 - $114.86 $3,088 - $3,445	30 Added 0.48%	6,306 $670,000
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $13,028 - $16,704	149 Added 2.43%	6,276 $696,000
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $46,914 - $52,702	555 Added 9.96%	6,127 $528,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $4,675 - $5,299	-56 Reduced 1.0%	5,572 $508,000
Q1 2022 Oct 13, 2022	SELL	$73.51 - $82.4 $808 - $906	-11 Reduced 0.2%	5,628 $462,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $808 - $906	-11 Reduced 0.2%	5,628 $462 Million
Q4 2021 Oct 13, 2022	SELL	$72.28 - $90.54 $114,130 - $142,962	-1,579 Reduced 21.88%	5,639 $432,000
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $114,130 - $142,962	-1,579 Reduced 21.88%	5,639 $432 Million
Q3 2021 Oct 13, 2022	BUY	$71.68 - $78.83 $17,346 - $19,076	242 Added 3.47%	7,218 $542,000
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $17,346 - $19,076	242 Added 3.47%	7,218 $542 Million
Q2 2021 Oct 13, 2022	SELL	$70.31 - $77.77 $31,920 - $35,307	-454 Reduced 6.11%	6,976 $543,000
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $140 - $155	-2 Reduced 0.03%	6,976 $542,000
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $31,124 - $36,661	-452 Reduced 6.08%	6,978 $537,000
Q4 2020 Oct 13, 2022	BUY	$71.77 - $79.65 $37,822 - $41,975	527 Added 7.63%	7,430 $608,000
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $37,822 - $41,975	527 Added 7.63%	7,430 $608 Million
Q3 2020 Oct 13, 2022	BUY	$73.18 - $82.95 $97,402 - $110,406	1,331 Added 23.89%	6,903 $573,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $66,666 - $75,567	911 Added 15.2%	6,903 $546,000
Q2 2020 Aug 05, 2020	SELL	$70.42 - $80.13 $172,951 - $196,799	-2,456 Reduced 29.07%	5,992 $463,000
Q1 2020 May 04, 2020	BUY	$63.36 - $87.82 $177,851 - $246,510	2,807 Added 49.76%	8,448 $650,000
Q4 2019 Feb 05, 2020	BUY	$77.58 - $87.54 $437,628 - $493,813	5,641 New	5,641 $513,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Merck & Co., Inc. Transaction History